Keywords: swiss, biotech, addex, set, get, over, 700m

Swiss biotech Addex set to get over $700M for licensing drug to Merck & Co

Article | 14 January 2008

Print This

In a second deal within a month between the two companies, US drug major Merck & Co has entered an agreement ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in